We are global contract development & manufacturing organization specialized in soft gelatin capsules, non-sterile liquid forms and R&D services.

Contact us!

DISCOVER MORE

Curtis Health Caps

During its 30-year presence on international markets, CHC has gained the reputation of a trusted partner providing services to clients from the pharmaceutical, food and cosmetic industries as well as manufacturers of medical and veterinary devices. What sets us apart at the moment is the so-called 'pure business model' - the absence of our own brands is part of CHC's long-term strategy.

FROM IDEA TO FINISHED PRODUCT

Development and manufacturing of products at CHC is covered by comprehensive services at all stages of work, starting from R&D services, through regulatory and quality consulting, manufacturing, to storage and transport.

Curtis Health Caps S.A.

Wysogotowo
ul. Batorowska 52
62-081 Przeźmierowo

www.chc.com.pl

bd@chc.com.pl

Go to article: Home | Improving safety for multiple drug regimes Go to article: In this issueGo to article: ContentsGo to article: Curtis Health CapsGo to article: Astrix Go to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Owen Mumford Company Insight Go to article: Owen MumfordGo to article: CommentGo to article: Use of AI in the fight against Covid-19 shows mixed results Go to article: What does Ireland’s tax hike mean for pharma?Go to article: Chinese review designations lag behind US and EUGo to article: The business benefits of text mining in life sciencesGo to article: Mettler ToledoGo to article: HOF SonderanlagenbauGo to article: In DepthGo to article: Narrow FDA panel vote on Merck’s molnupiravir bolsters outlook on mAbsGo to article: The challenges of multiple drugs safety reportingGo to article: 3D printing in drug manufacturing: unlocking future possibilitiesGo to article: Can drug repurposing uncover better treatments for UTIs?Go to article: Pfizer and Takeda deals put a spotlight on value-based pricing Go to article: Lethal injection: can pharma kill the death penalty?Go to article: Mimotopes Company Insight Go to article: MimotopesGo to article: In DataGo to article: Middle-income countries’ healthcare sectors to keep rising through to 2024Go to article: Data analytics hiring levels in clinical trial operations rose in OctoberGo to article: Industrial automation innovation in pharma rebounded in the last quarterGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: YearbookGo to article: SHL MedicalGo to article: Dr. Paul Lohmann Company Insight Go to article: Dr. Paul LohmannGo to article: Novo NordiskGo to article: NiproGo to article: EventsGo to article: Next issue